
Appetite suppressant and weight management protocols will be established where necessary by the medical director.
Tirzepatide / Pyridoxine is a combination injectable formulation designed to support metabolic health, weight management, and energy balance. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that plays a key role in appetite regulation, glycemic control, and metabolic signaling. Pyridoxine (Vitamin B-6) is included to support amino acid metabolism, neurotransmitter synthesis, and energy production.
This multi-dose vial formulation allows for precise dosing and individualized titration under licensed medical supervision. The combination is commonly incorporated into comprehensive metabolic and weight management protocols where appetite control, insulin sensitivity, and metabolic efficiency are clinical priorities. This multi-dose vial (MDV) formulation allows for precise dosing and individualized titration under licensed medical supervision.